Nurse Practitioner in Crested Butte, CO Accepting Medicare

4 Nurse Practitioner nurses found. Showing 1 - 4

Brianna Kellett, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 217 Elk Ave Ste 2222, Crested Butte, CO 81224 Phone: 866-849-0692

Miss Alison Christine Risk, FNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 405 Elk Avenue, Crested Butte, CO 81224 Phone: 970-349-1046    Fax: 973-491-1049

Shannon Bedore, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 217 Maroon Ave, Crested Butte, CO 81224 Phone: 916-955-1147

Mrs. Alyse Poll, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 217 Elk Ave Ste 2222, Crested Butte, CO 81224 Phone: 866-849-0692

News Archive

Celltrion develops novel human monoclonal antibodies against influenza virus infection

Celltrion, Inc., a South Korean biopharmaceutical company, has developed novel human monoclonal antibodies against influenza virus infection, which neutralize a broad spectrum of influenza viruses, including pandemic H1N1 and the deadly H5N1 avian influenza virus. Preliminary tests in laboratory animals indicate that the novel human monoclonal antibodies can be used to prevent disease when given either before or after infection.

Pharma IQ publishes results of Industry-wide distribution survey

Pharma IQ has just published the results of an Industry-wide Pharmaceutical Distribution Survey, conducted recently among 3,000 pharmaceutical distribution specialist with over 83 % of those surveyed directly responsible for distribution at their respective companies.

Insilico Medicine collaborates with Asia Genomics to develop advanced personalized longevity suite

Insilico Medicine Inc, a big data analytics company located at the Emerging Technology Centers at the Johns Hopkins University at Eastern, announced an agreement with Asia Genomics, a Singapore-based rapidly growing molecular diagnostics company specializing in clinical genomics & genetic testing operating in major Asian countries including Vietnam, Malaysia and China.

CVAF completes new investment agreement with Oncovir for production of Hiltonol

Cancer Research Institute, Inc. (CRI), a U.S. nonprofit organization founded in 1953 to advance the science of tumor immunology and foster the discovery and development of new cancer immunotherapies, announced today that its Cancer Vaccine Acceleration Fund (CVAF), a joint initiative with the Ludwig Institute for Cancer Research (LICR), has completed a new investment agreement with Oncovir, Inc., a biotechnology company based in Washington, D.C., to enable the production of the immunological stimulant Hiltonol® (Poly-ICLC).

Read more Medical News

› Verified 1 days ago